According to a report by Decrypt on October 10, Microsoft Vice President Peter Lee delivered a keynote speech on artificial intelligence and health care at the "Health and Longevity Global Innovators Summit", believing that applying artificial intelligence to medicine and longevity research will be a "net positive" benefit". Lee said GPT-4 could help restore "family harmony" in medical conversations and could help enable new scientific discoveries, drugs, treatments and diagnostics in many areas. Additionally, Lee noted that artificial intelligence, which has proven to be good at identifying flaws in medical research, can introduce the same flaws when asked to write its own reports. “GPT-4 consistently outperforms human reviewers in identifying biased, harmful, and non-inclusive language in submitted manuscripts in a way that human reviewers cannot,” he observed. "Nonetheless, if GPT-4 were asked to write the same paper on its own, it would likely be guilty of the same bias."

Odaily Planet Daily reported that VitaDAO, a DeSci (decentralized science) project invested by pharmaceutical giant Pfizer, recently spun off a biotechnology company, Matrix Biosciences. Matrix Biosciences, a biotech company led by Vera Gorbunova, an anti-aging researcher at the University of Rochester, has an initial funding of $300,000 for the project, with more funding to be available in early 2024. The company aims to conduct research on the longevity and cancer-fighting properties of naked mole rats, and to study whether compounds found in naked mole rats could extend human lifespan. (blockworks)

VitaDAO Founds Biotech Firm to Advance Longevity Research, Develop Treatments for Cancer and Age-related Diseases VitaDAO, a decentralized autonomous organization (DAO), has launched Matrix Biosciences, a biotech company focused on advancing longevity research. Matrix Biosciences, majority-owned by VitaDAO, will operate as a centralized entity and work on developing treatments for cancer and age-related diseases using research on the naked mole-rat. The company aims to demonstrate the compatibility of blockchain technology with the biotech industry and is actively collaborating with regulators to ensure compliance.

PANews reported on October 9 that according to Decrypt, VitaDAO, a decentralized autonomous organization that aims to fund longevity research projects, has cooperated with famous biologist Vera Gorbunova to establish Matrix Biosciences, a biotechnology company that studies longevity. The company’s majority shareholder is VitaDAO, but due to the strict legal environment in the medical and healthcare fields, the company itself will still operate as a traditional company. VitaDAO will initially provide $300,000 in funding to Matrix Biosciences. The joint venture will then receive additional capital through its IP-NFT segmentation model. VitaDAO core member Eleanor Davies said Matrix Biosciences will study the anti-cancer, anti-pain and life-extending properties of a special substance rich in high molecular weight hyaluronic acid (HMW-HA) secreted by naked mole rats. It was reported in January this year that VitaDAO, a longevity research organization, completed US$4.1 million in financing, with Pfizer’s venture capital firm participating in the investment. Related reading: Can VitaDAO, which received investment from Pfizer, start a new narrative of decentralized science?

Golden Finance reports that VitaDAO, a community organization that funds and promotes early longevity research, announced that it has partnered with world-renowned biologist Vera Gorbunova to establish Matrix Biosciences. Gorbunova, a professor at the University of Rochester, is credited with discovering the anti-cancer properties of naked mole rats. Todd White, a core member of VitaDAO, said the idea behind the new company is to “bring the research within the DAO back into the real world” rather than keeping it on-chain. Matrix Biosciences will operate centrally like a traditional company.

According to the Financial Associated Press on August 22, Japanese scientists have developed an advanced artificial intelligence (AI) model that can accurately estimate a patient's actual age using chest X-ray images. What's more, AI can also reveal chronic diseases in patients when large discrepancies between estimated and true ages are found. The discovery marks a quantum leap in medical imaging, paving the way for improved early disease detection and intervention. The findings were published in the latest issue of the journal The Lancet Health and Longevity.

According to Shanghai Securities News, Liang Jianzhang, chairman of the board of directors of Ctrip Group and a well-known population economist, recently announced that he will adapt his novel "After Immortality" into an immersive audio-visual drama. A few days ago, regarding the original intention and concept of creating the play, Liang Jianzhang said in an interview with Shanghai Securities News: Inheritance and innovation are the privileges that distinguish humans from AI. The novel "After Eternal Life" is set against the background of the invention of the "Pharmaceutical of Immortality", and depicts a human civilization that has stopped multiplying and changed generations because of "Eternal Life". In the 22nd century AD, with the development of biotechnology, human beings finally developed the "Pharmacy of Immortality". However, the earth's resources are limited, and "immortality" and "reproduction" cannot be achieved at the same time. Human beings on the earth are divided into "longevity zone" and "life and death zone" according to their own wishes, and the two sides develop independently according to their own concepts. It is worth mentioning that Liang Jianzhang, as an expert in "birth promotion", has always encouraged young people to have more children. Recently, Ctrip Group announced that starting from July 1, all Ctrip employees who have been employed for three years can receive 10,000 yuan of maternity subsidies every year for five consecutive years after giving birth. According to preliminary estimates, Ctrip plans to invest 1 billion yuan in maternity subsidies in the future to encourage employees to have children.

The 11 major technological trends worth paying attention to in 2023 released by CBInsights: 1. Longevity Technology 2. Super app 3. The rapid regeneration of financial technology 4. Household robots 5. Virtual Power Plant 6. Smart healthcare 7. Digital smell 8. Women's health technology 9. The upsurge of bio-based materials 10. Rise of technology in India 11. Regenerative agricultural technology